The experimental modification of lysosomal dysfunction by anti-inflammatory drugs acting in vitro.
D000082:Acetaminophen / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001241:Aspirin / Q000494:pharmacology; D002478:Cells, Cultured; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007249:Inflammation; D008247:Lysosomes / Q000187:drug effects*; D008566:Membranes / Q000187:drug effects; D010539:Permeability; D012459:Salicylates / Q000494:pharmacology; D012871:Skin Diseases / Q000188:drug therapy; D013583:Synovial Membrane / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D012459:Salicylates; D000082:Acetaminophen; D006632:Histamine; D001241:Aspirin